| Lashonda Moore, DPM | |
|
220 Fort Dale Rd, Greenville, AL 36037-1502 | |
| (334) 382-1400 | |
| Not Available |
| Full Name | Lashonda Moore |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 25 Years |
| Location | 220 Fort Dale Rd, Greenville, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518993310 | NPI | - | NPPES |
| 051533097 | Other | AL | BC MONTGOMERY OFFICE |
| 051532094 | Other | AL | BC CEDARS ASSISTED LIVING |
| 890014860 | Medicaid | AL | |
| P00289903 | Other | AL | RAILROAD MEDICARE |
| 051532095 | Other | AL | BC ELMCROFT ASSISTED LIVI |
| 890014840 | Medicaid | AL | |
| 890014890 | Medicaid | AL | |
| 051532088 | Other | AL | BC GREENVILLE OFFICE |
| 051532089 | Other | AL | BC SNF SUNBRIDGE |
| 051532090 | Other | AL | BC SNF BELLMONT ASSISTED |
| 051532091 | Other | AL | BC HILLABER TOWERS ALEX C |
| 891011570 | Medicaid | AL | |
| 891011610 | Medicaid | AL | |
| 051533098 | Other | AL | BC CLANTON OFFICE |
| 891011600 | Medicaid | AL | |
| 891011620 | Medicaid | AL | |
| 051532092 | Other | AL | BC COUNTY CLUB MANOR WETU |
| 890014810 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213EP1101X | Podiatrist - Primary Podiatric Medicine | 261 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| 360care Services Of Al Llc | 7719240977 | 25 |
| Greenville Footcare Llc | 7810919610 | 2 |
News Archive
New research led by scientists at the University of North Carolina at Chapel Hill School of Medicine have found a drug target that suggests a potent way to kill colon cancers that resist current drugs aimed at blocking a molecule found on the surface of cells.
Arrowhead Research Corporation announced today that its portfolio company, Leonardo Biosystems, has received a $2.5 million grant from the Texas Emerging Technology Fund, a state fund established to accelerate commercialization of new technologies. Leonardo Biosystems, co-founded by prominent nanoscientist Dr. Mauro Ferrari, professor at the University of Texas, and Arrowhead's, CEO Dr. Christopher Anzalone, is engineering a multi-stage drug delivery platform to improve the effectiveness of drug therapy, particularly for cancer.
For centuries, it has been generally believed women are the more sensitive gender. A new study says that, when it comes to pain, women are in fact more sensitive.
Researchers have reversed lung fibrosis in a mouse model of idiopathic pulmonary fibrosis, or IPF, as reported in a study published in the journal Cell Death and Differentiation.
Results from a large, international survey shows that only a small fraction of children with rheumatic diseases reported contracting COVID-19.
› Verified 9 days ago
| Provider Name | Greenville Footcare Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851324271 PECOS PAC ID: 7810919610 Enrollment ID: O20051221000315 |
News Archive
New research led by scientists at the University of North Carolina at Chapel Hill School of Medicine have found a drug target that suggests a potent way to kill colon cancers that resist current drugs aimed at blocking a molecule found on the surface of cells.
Arrowhead Research Corporation announced today that its portfolio company, Leonardo Biosystems, has received a $2.5 million grant from the Texas Emerging Technology Fund, a state fund established to accelerate commercialization of new technologies. Leonardo Biosystems, co-founded by prominent nanoscientist Dr. Mauro Ferrari, professor at the University of Texas, and Arrowhead's, CEO Dr. Christopher Anzalone, is engineering a multi-stage drug delivery platform to improve the effectiveness of drug therapy, particularly for cancer.
For centuries, it has been generally believed women are the more sensitive gender. A new study says that, when it comes to pain, women are in fact more sensitive.
Researchers have reversed lung fibrosis in a mouse model of idiopathic pulmonary fibrosis, or IPF, as reported in a study published in the journal Cell Death and Differentiation.
Results from a large, international survey shows that only a small fraction of children with rheumatic diseases reported contracting COVID-19.
› Verified 9 days ago
| Provider Name | 360care Services Of Al Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1710493176 PECOS PAC ID: 7719240977 Enrollment ID: O20180423000351 |
News Archive
New research led by scientists at the University of North Carolina at Chapel Hill School of Medicine have found a drug target that suggests a potent way to kill colon cancers that resist current drugs aimed at blocking a molecule found on the surface of cells.
Arrowhead Research Corporation announced today that its portfolio company, Leonardo Biosystems, has received a $2.5 million grant from the Texas Emerging Technology Fund, a state fund established to accelerate commercialization of new technologies. Leonardo Biosystems, co-founded by prominent nanoscientist Dr. Mauro Ferrari, professor at the University of Texas, and Arrowhead's, CEO Dr. Christopher Anzalone, is engineering a multi-stage drug delivery platform to improve the effectiveness of drug therapy, particularly for cancer.
For centuries, it has been generally believed women are the more sensitive gender. A new study says that, when it comes to pain, women are in fact more sensitive.
Researchers have reversed lung fibrosis in a mouse model of idiopathic pulmonary fibrosis, or IPF, as reported in a study published in the journal Cell Death and Differentiation.
Results from a large, international survey shows that only a small fraction of children with rheumatic diseases reported contracting COVID-19.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lashonda Moore, DPM 220 Fort Dale Rd, Greenville, AL 36037-1502 Ph: (334) 382-1400 | Lashonda Moore, DPM 220 Fort Dale Rd, Greenville, AL 36037-1502 Ph: (334) 382-1400 |
News Archive
New research led by scientists at the University of North Carolina at Chapel Hill School of Medicine have found a drug target that suggests a potent way to kill colon cancers that resist current drugs aimed at blocking a molecule found on the surface of cells.
Arrowhead Research Corporation announced today that its portfolio company, Leonardo Biosystems, has received a $2.5 million grant from the Texas Emerging Technology Fund, a state fund established to accelerate commercialization of new technologies. Leonardo Biosystems, co-founded by prominent nanoscientist Dr. Mauro Ferrari, professor at the University of Texas, and Arrowhead's, CEO Dr. Christopher Anzalone, is engineering a multi-stage drug delivery platform to improve the effectiveness of drug therapy, particularly for cancer.
For centuries, it has been generally believed women are the more sensitive gender. A new study says that, when it comes to pain, women are in fact more sensitive.
Researchers have reversed lung fibrosis in a mouse model of idiopathic pulmonary fibrosis, or IPF, as reported in a study published in the journal Cell Death and Differentiation.
Results from a large, international survey shows that only a small fraction of children with rheumatic diseases reported contracting COVID-19.
› Verified 9 days ago
Dr. Brian N Kille, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 220 Fortdale Rd, Greenville, AL 36037 Phone: 334-382-1400 | |
Greenville Footcare Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 220 Fort Dale Rd, Greenville, AL 36037 Phone: 334-382-1400 |